Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6363441rdf:typepubmed:Citationlld:pubmed
pubmed-article:6363441lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:6363441lifeskim:mentionsumls-concept:C0028754lld:lifeskim
pubmed-article:6363441lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:6363441lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:6363441lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:6363441lifeskim:mentionsumls-concept:C0021641lld:lifeskim
pubmed-article:6363441lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:6363441lifeskim:mentionsumls-concept:C0683598lld:lifeskim
pubmed-article:6363441lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:6363441pubmed:issue3lld:pubmed
pubmed-article:6363441pubmed:dateCreated1984-3-12lld:pubmed
pubmed-article:6363441pubmed:abstractTextTo compare the ability of insulin to regulate lipolysis in lean and obese subjects, free fatty acid (FFA) suppression was compared in groups of six lean [body mass index, 25.7 +/- 1.1 (+/-SEM) kg/m2] and six obese (body mass index, 48.8 +/- 3.1) Pima Indians during euglycemic hyperinsulinemic clamps which increased plasma insulin levels approximately 10, 20, and 100 microU/ml above basal concentrations. Basal FFA concentrations were slightly, but not significantly, elevated in the obese group (445 +/- 35 vs. 406 +/- 40 mu eg/liter). The mean decline in FFA from basal after 60-90 min of insulin infusion in the obese group was somewhat less than that in the lean group at the lower doses [67 +/- 23 vs. 132 +/- 32 (P = NS) during the 10-microU clamp, and 144 +/- 39 vs. 217 +/- 20 (P = NS) during the 20-microU clamp] and was almost identical in the two groups during the 100-microU clamp (226 +/- 29 vs. 229 +/- 51). In contrast, insulin-mediated glucose disposal at all insulin increments was much lower in the obese group (0.33 +/- 0.03, 0.56 +/- 0.04, and 1.39 +/- 0.04 mg/kg X min) than in the lean group (0.78 +/- 0.06, 1.67 +/- 0.12, and 4.96 +/- 0.26; P less than 0.001). The data suggest that although the obese subjects exhibited significant resistance to the glucoregulatory action of insulin, there were only small changes in insulin's antilipolytic effects. Relative maintenance of sensitivity to the antilipolytic action of insulin in the presence of resistance to insulin's glucoregulatory action could maintain fat deposition in obese individuals.lld:pubmed
pubmed-article:6363441pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6363441pubmed:languageenglld:pubmed
pubmed-article:6363441pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6363441pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6363441pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6363441pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6363441pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6363441pubmed:statusMEDLINElld:pubmed
pubmed-article:6363441pubmed:monthMarlld:pubmed
pubmed-article:6363441pubmed:issn0021-972Xlld:pubmed
pubmed-article:6363441pubmed:authorpubmed-author:KlimesIIlld:pubmed
pubmed-article:6363441pubmed:authorpubmed-author:UngerR HRHlld:pubmed
pubmed-article:6363441pubmed:authorpubmed-author:VasquezBBlld:pubmed
pubmed-article:6363441pubmed:authorpubmed-author:HowardB VBVlld:pubmed
pubmed-article:6363441pubmed:authorpubmed-author:NagulesparanM...lld:pubmed
pubmed-article:6363441pubmed:authorpubmed-author:BradtCClld:pubmed
pubmed-article:6363441pubmed:issnTypePrintlld:pubmed
pubmed-article:6363441pubmed:volume58lld:pubmed
pubmed-article:6363441pubmed:ownerNLMlld:pubmed
pubmed-article:6363441pubmed:authorsCompleteYlld:pubmed
pubmed-article:6363441pubmed:pagination544-8lld:pubmed
pubmed-article:6363441pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:6363441pubmed:meshHeadingpubmed-meshheading:6363441-...lld:pubmed
pubmed-article:6363441pubmed:meshHeadingpubmed-meshheading:6363441-...lld:pubmed
pubmed-article:6363441pubmed:meshHeadingpubmed-meshheading:6363441-...lld:pubmed
pubmed-article:6363441pubmed:meshHeadingpubmed-meshheading:6363441-...lld:pubmed
pubmed-article:6363441pubmed:meshHeadingpubmed-meshheading:6363441-...lld:pubmed
pubmed-article:6363441pubmed:meshHeadingpubmed-meshheading:6363441-...lld:pubmed
pubmed-article:6363441pubmed:meshHeadingpubmed-meshheading:6363441-...lld:pubmed
pubmed-article:6363441pubmed:meshHeadingpubmed-meshheading:6363441-...lld:pubmed
pubmed-article:6363441pubmed:year1984lld:pubmed
pubmed-article:6363441pubmed:articleTitleThe antilipolytic action of insulin in obese subjects with resistance to its glucoregulatory action.lld:pubmed
pubmed-article:6363441pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6363441pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6363441lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6363441lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6363441lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6363441lld:pubmed